7 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Influenza in Birds"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca
2 Recruiting Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 Anhui 2013/AA ca;   Biological: Inactivated subvirion H7N9 vaccine
3 Recruiting A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects
Condition: H7N9 Influenza Vaccine
Interventions: Biological: AT-501 High Dose vaccine;   Biological: AT-501 High Dose vaccine with Adjuvant;   Biological: AT-501 Low Dose vaccine;   Biological: AT-501 Low Dose vaccine with Adjuvant
4 Recruiting Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention: Drug: Menstrual blood stem cells
5 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
6 Not yet recruiting A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2
7 Not yet recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age
Condition: Influenza
Interventions: Biological: Investigational H7N9 vaccine GSK3277510A;   Biological: Investigational H7N9 vaccine GSK3277509A;   Biological: Placebo

Indicates status has not been verified in more than two years